Back to search

Article

Osteoclast-Cancer Cell Metabolic Symbiosis Renders PARP Inhibitor Therapy Resistance in Bone Metastasis

2023-08-16

Abstract excerpt

<h4>ABSTRACT</h4> Seventy percent of patients with late-stage breast cancer develop distal bone metastases; however, the mechanism by which the metabolic microenvironment affects resistance to therapy remains unknown. We investigated the metabolic bone microenvironment and identified glutathione metabolism as the top pathway in osteoclasts, which provides feedback to tumor cells to help neutralize oxidative stres...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
7670bcc7-b34a-5e04-b722-33dad981ab44
DOI
10.1101/2023.08.15.553338
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Osteoclast-Cancer Cell Metabolic Symbiosis Renders PARP Inhibitor Therapy Resistance in Bone MetastasisDOI 10.1101/2023.08.15.553338
Select a neighboring publication to make it the new centre.